OPPI’s Matai On Section 3(d) Of India’s Patent Regulations: Now’s The Time To Open Up

Industry Group’s Head Shares Views In Audio Interview

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.